Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $23.97 million. The enterprise value is -$7.59 million.
| Market Cap | 23.97M |
| Enterprise Value | -7.59M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 35.25 million shares outstanding. The number of shares has increased by 2.44% in one year.
| Shares Outstanding | 35.25M |
| Shares Change (YoY) | +2.44% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 36.42% |
| Owned by Institutions (%) | 20.04% |
| Float | 17.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| Forward PS | n/a |
| PB Ratio | 1.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.91 |
| Quick Ratio | 1.68 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -43.82 |
Financial Efficiency
Return on equity (ROE) is -51.20% and return on invested capital (ROIC) is -60.54%.
| Return on Equity (ROE) | -51.20% |
| Return on Assets (ROA) | -23.30% |
| Return on Capital (ROIC) | -60.54% |
| Revenue Per Employee | $861,227 |
| Profits Per Employee | -$275,659 |
| Employee Count | 44 |
| Asset Turnover | 0.73 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $520,000 in taxes.
| Income Tax | 520,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.50% in the last 52 weeks. The beta is 1.81, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -12.50% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 28.87 |
| Average Volume (20 Days) | 818,147 |
Short Selling Information
The latest short interest is 274,881, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 274,881 |
| Short Previous Month | 199,544 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 1.55% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
In the last 12 months, Equillium had revenue of $37.89 million and -$12.13 million in losses. Loss per share was -$0.35.
| Revenue | 37.89M |
| Gross Profit | 37.89M |
| Operating Income | -13.21M |
| Pretax Income | -11.61M |
| Net Income | -12.13M |
| EBITDA | -11.22M |
| EBIT | -11.35M |
| Loss Per Share | -$0.35 |
Balance Sheet
The company has $32.29 million in cash and $719,000 in debt, giving a net cash position of $31.57 million or $0.90 per share.
| Cash & Cash Equivalents | 32.29M |
| Total Debt | 719,000 |
| Net Cash | 31.57M |
| Net Cash Per Share | $0.90 |
| Equity (Book Value) | 21.09M |
| Book Value Per Share | 0.60 |
| Working Capital | 20.27M |
Cash Flow
In the last 12 months, operating cash flow was -$22.59 million and capital expenditures -$69,000, giving a free cash flow of -$22.66 million.
| Operating Cash Flow | -22.59M |
| Capital Expenditures | -69,000 |
| Free Cash Flow | -22.66M |
| FCF Per Share | -$0.64 |
Margins
Gross margin is 100.00%, with operating and profit margins of -34.85% and -32.01%.
| Gross Margin | 100.00% |
| Operating Margin | -34.85% |
| Pretax Margin | -30.64% |
| Profit Margin | -32.01% |
| EBITDA Margin | -29.62% |
| EBIT Margin | -29.95% |
| FCF Margin | -59.79% |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.44% |
| Shareholder Yield | -2.44% |
| Earnings Yield | -50.59% |
| FCF Yield | -94.51% |
Analyst Forecast
The average price target for Equillium is $3.90, which is 473.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.90 |
| Price Target Difference | 473.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -4.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.85 |
| Piotroski F-Score | 2 |